About Amicus Therapeutics, Inc

At Amicus Therapeutics, Inc we try to make all our decisions as if we were living with a rare disease or were caring for someone who is. We ask ourselves "what would be important to me" if I was a person living with Fabry disease? What would be a meaningful advancement or a risk I would take? To that end, we:

  • Listen and learn from individuals and their families affected by these diseases;
  • Search for new and better therapies;
  • Incorporate patient input into the design of clinical trials for those therapies as our research advances through the drug development process; and
  • Provide useful information and resources to help manage the daily challenges of living with a rare, genetic disease.

Amicus Therapeutics is a global biotechnology company at the forefront of advanced therapies to treat a range of serious rare diseases.